Skip to content

Anti-fatigue effects of olive-oil administration in cross-over study.

Anti-fatigue effects of olive-oil administration in cross-over study. - The anti-fatigue effects of olive-oil administration.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032487
Enrollment
30
Registered
2019-03-31
Start date
2016-09-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Administration of test oil for 4 weeks. / Wash out for 4 weeks. / Administration of placebo oil for 4 weeks. Administration of placebo oil for 4 weeks. / Wash out for 4 weeks. / Administration of tes

Sponsors

Osaka City University Center for Health Science Innovation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy persons who are aged from 20 to 64 years. 2.Persons who can give written informed consents.

Exclusion criteria

Exclusion criteria: 1.Persons who are in treatment. 2.Persons who have medical history of cardiovascular disease. 3.Persons who have autonomic nervous system dysfunction. 4.Persons who have medical history of nervous system disease such as unconsciousness, coma, convulsion, etc. 5.Persons who have insomnia. 6.Persons who have food allergy. 7.Persons who are heavy user of alcohol. 8.Persons whose body mass index is less than 17 and more than 31. 9.Persons who are on a diet. 10.Pregnant women. 11.Persons who usually take in olive oil. 12.Persons who have past or current medical history of serious disease such as diabetes mellitus, hepatic disease, kidney disease, cardiac disease, cholelithiasis, etc. 13.Persons who are now participating in other clinical trials, or participated in other clinical trials within a month before obtaining his/her informed consent in this trial. 14.Persons who are judged not suitable to participate in this trial by investigators.

Design outcomes

Primary

MeasureTime frame
Changes in autonomic nerve function, oxidation stress, antioxidant activity, cognitive function, sleep state and subjective fatigue after 4-weeks administration.

Secondary

MeasureTime frame
Amount of daily activity

Countries

Japan

Contacts

Public ContactKei Mizuno

Osaka City University Center for Health Science Innovation

chsi-b@ado.osaka-cu.ac.jp06-6485-0288

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026